Dopamine Infusion Rate Calculator

💧 Dopamine Infusion Rate Calculator

Titration Guide for Hemodynamic Support

Total Dopamine to Mix (mg) (in 100mg increments)

ⓘ Note: Common premixed concentrations are 400mg in 250mL (1600 mcg/mL) or 800mg in 250mL (3200 mcg/mL).

Titration Guide

Concentration: — mcg/mL

Dose (mcg/kg/min) Rate (mL/hr)
Enter patient and drug information.
Renal/Dopaminergic (<5 mcg/kg/min) Increases renal blood flow. Use for renal protection is abandoned and not recommended (no proven benefit; arrhythmia risk).
Inotropic/Beta (5-10 mcg/kg/min) Increases heart contractility and cardiac output.
Pressor/Alpha (>10 mcg/kg/min) Causes vasoconstriction to increase blood pressure.
Show calculation steps

Recent Updates

  • Norepinephrine is strongly recommended over dopamine (high certainty of evidence).
  • Clarified that low-dose “renal” dopamine is abandoned, not merely controversial.
  • Updated the primary guideline reference to the 2026 Surviving Sepsis Campaign.

Source: Prescott HC, Antonelli M, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026. Intensive Care Medicine 2026. doi:10.1007/s00134-026-08361-1.

Key Knowledge Points

  • This Dopamine Infusion Rate Calculator is for a potent catecholamine with dose-dependent effects: low doses for renal effects, medium for inotropy, and high for vasopressor action.
  • Low-dose “renal dose” dopamine for kidney protection has been abandoned and is not recommended (including by the 2026 Surviving Sepsis Campaign) because it has no proven benefit and carries arrhythmia risk; no renal-protective indication remains valid.
  • The 2026 Surviving Sepsis Campaign (SSC 2026) recommends norepinephrine as the first-line vasopressor over dopamine — a strong recommendation with high certainty of evidence, the strongest of the vasopressor comparisons. Dopamine carries a higher risk of tachyarrhythmias (SOAP II). SSC 2026 does not give dopamine a dedicated “use only if…” carve-out; any niche use (e.g., relative bradycardia with low arrhythmia risk) reflects clinical judgment rather than a 2026 guideline statement.
  • Central line administration is strongly recommended to prevent severe tissue necrosis from extravasation (drug leakage).
  • Always ensure the patient is adequately fluid-resuscitated before and during dopamine therapy to avoid exacerbating hypotension.

About This Dopamine Infusion Rate Calculator

This Dopamine Infusion Rate Calculator is a clinical tool designed for the critical care setting to aid in the safe and effective administration of dopamine. By inputting the patient’s weight and the prepared IV bag concentration, this calculator generates a comprehensive titration table. The table provides the precise infusion rates (mL/hr) for a range of standard weight-based doses (mcg/kg/min) and clarifies the expected primary clinical effect at each dose level. This helps clinicians quickly titrate therapy to the desired hemodynamic effect.

The Formula Explained

The calculation converts a weight-based dose into a volumetric infusion rate based on the IV bag’s concentration. The formula used by this Dopamine Infusion Rate Calculator is:

$$ \text{Rate (mL/hr)} = \frac{\text{Dose (mcg/kg/min)} \times \text{Weight (kg)} \times 60 \text{ min/hr}}{\text{Concentration (mcg/mL)}} $$

Clinical Interpretation & Limitations

The clinical effects of dopamine are directly related to the infusion rate, targeting different receptors at varying doses. The results from this Dopamine Infusion Rate Calculator should be used as a guide for titration.

  • Low Dose (1-5 mcg/kg/min): Primarily stimulates dopaminergic (D1) receptors, leading to renal and mesenteric vasodilation. Use of this “renal dose” has been abandoned and is not recommended for renal protection, as it has no proven benefit and carries arrhythmia risk.
  • Moderate Dose (5-10 mcg/kg/min): Primarily stimulates beta-1 adrenergic receptors, increasing heart contractility and cardiac output (inotropic effect).
  • High Dose (>10 mcg/kg/min): Primarily stimulates alpha-1 adrenergic receptors, causing systemic vasoconstriction and an increase in blood pressure (vasopressor effect).

Limitations

The dose-effect relationship is a spectrum, not a series of absolute cutoffs; effects overlap. This calculator provides a starting point, but the ultimate guide must be the patient’s hemodynamic response. The 2026 Surviving Sepsis Campaign (SSC 2026) recommends norepinephrine as the first-line vasopressor over dopamine — a strong recommendation supported by high certainty of evidence and the strongest of the vasopressor comparisons — given dopamine’s higher incidence of tachyarrhythmias (SOAP II). SSC 2026 does not carve out a dedicated “use only if…” indication for dopamine; any niche use reflects clinical judgment rather than a 2026 guideline statement.

Frequently Asked Questions (FAQ)

1. Is “renal dose” dopamine still used to protect the kidneys?

The routine use of low-dose dopamine solely for renal protection has been abandoned and is no longer considered a valid indication. Major clinical guidelines, including the 2026 Surviving Sepsis Campaign, do not recommend it, as studies have failed to show a benefit in preventing or treating acute kidney injury and it may cause harmful side effects like arrhythmias.

2. What is extravasation and how is it managed?

Extravasation is the leakage of a vesicant drug like dopamine from the vein into the surrounding tissue, which can cause severe vasoconstriction and lead to tissue death (necrosis). If it occurs, the infusion should be stopped immediately, and the area may be infiltrated with an antidote like phentolamine per institutional protocol.

3. Why is norepinephrine often preferred over dopamine in septic shock?

Large clinical trials (notably SOAP II / De Backer, NEJM 2010) have shown that dopamine is associated with a higher rate of adverse events, particularly tachyarrhythmias, compared to norepinephrine in patients with septic shock. On this basis, the 2026 Surviving Sepsis Campaign (SSC 2026) recommends norepinephrine as the first-line vasopressor over dopamine — a strong recommendation with high certainty of evidence, the strongest of the vasopressor comparisons. SSC 2026 does not give dopamine a dedicated “use only if…” carve-out; any niche use reflects clinical judgment rather than a 2026 guideline statement.

4. What are the main parameters to monitor on a dopamine drip?

Continuous monitoring of heart rate, cardiac rhythm (ECG), and blood pressure (ideally with an arterial line) is essential. Clinicians also monitor peripheral perfusion (skin temperature, capillary refill), and signs of end-organ function like urine output and mental status.

5. How does this Dopamine Infusion Rate Calculator help in titration?

It provides a clear, pre-calculated reference chart that directly links the desired clinical effect (e.g., inotropic vs. vasopressor) to a specific dose in mcg/kg/min and the required pump rate in mL/hr. Using a dedicated Dopamine Infusion Rate Calculator reduces the need for manual calculations during titration, minimizing the risk of error.

⚠️ Disclaimer:

This tool is for informational and educational purposes only and is not a substitute for professional clinical judgment. All treatment decisions must be made by a qualified healthcare professional considering the individual patient’s full clinical context.